APRIL 26, 2021
Biophytis gives operational perspectives on its Sarconeos (BIO101) ahead of its upcoming AGM on April 26, 2021
APRIL 13, 2021
Biophytis Identifies False Report Regarding COVA Study
APRIL 7, 2021
Stanislas Veillet, CEO of Biophytis, reviews the company’s latest news in this interview with Laurent Grassin from Journal des Biotechs, covering listing on Nasdaq, Covid-19 clinical studies, expected clinical data in sarcopenia and the legal case with Negma.
MARCH 22, 2021
Biophytis gives updates on its Phase 2-3 COVA study on COVID-19
MARCH 19, 2021
Judgment of the Paris Commercial Court of March 16, 2021 in the case of Biophytis against Negma Group Ltd
MARCH 10, 2021
Biophytis AGM meeting will take place on April 26, 2021
FEBRUARY 10, 2021
Biophytis Announces Trading Resumption of its Ordinary Shares and Share Warrants on Euronext